Pharma giants Sanofi SA and GlaxoSmithKline PLC (GSK) yesterday said that they have agreed to supply Britain with up to 60 million doses of a potential COVID-19 vaccine.
The agreement covers a vaccine candidate developed by France’s Sanofi in partnership with the UK’s GSK and is subject to a “final contract.”
Amid a race to find a vaccine to halt the pandemic, Sanofi announced “ongoing discussions with the European Commission, with France and Italy on the negotiation team, and other governments to ensure global access to a novel coronavirus vaccine.”
Both companies voiced in a statement their commitment “to making their COVID-19 vaccine candidate affordable and available globally.”
The vaccine candidate “has the potential to play a significant role in overcoming the COVID-19 pandemic, both in the UK and around the world,” GSK Vaccines president Roger Connor said.
Sanofi predicted regulatory approval for the vaccine “could be achieved by the first half of 2021.”
British Secretary of State for Business, Energy and Industrial Strategy Alok Sharma, quoted in the statement, hailed the progress, but said that “the fact remains that there are no guarantees.”
“In the meantime, it is important that we secure early access to a diverse range of promising vaccine candidates, like GSK and Sanofi, to increase our chances of finding one that works so we can protect the public and save lives,” Sharma said.
Britain has already secured access to 90 million doses of potential coronavirus vaccines in deals with biotech firms BioNTech SE, Pfizer Inc and Valneva SE.
The deals involve 30 million doses of a vaccine being developed by US pharma giant Pfizer and Germany’s BioNTech, and 60 million doses of another created by France’s Valneva.
The government in London has also said that it would purchase 100 million doses of a vaccine being trialed by the University of Oxford in partnership with AstraZeneca PLC.
“This diversity of vaccine types is important because we do not yet know which, if any, of the different types of vaccine will prove to generate a safe and protective response to COVID-19,” Kate Bingham, chairwoman of the British government’s vaccine task force, was quoted as saying.
END TO SPECULATION: The hotel’s management contract has been extended, despite reports that it wanted to end its alliance with Hyatt Hotels over a deal with Riant Capital Singapore-based Hong Leong Hotel Development Ltd (豐隆大飯店股份) yesterday said it has extended a management contract to ensure the continued presence of the Grand Hyatt brand in Taipei, ending rumors that the two sides were parting ways. “We are pleased Hyatt is able to come to terms on the extension of the management contract of Grand Hyatt Taipei,” said Kwek Leng Beng (郭令明), executive chairman of City Developments Ltd (城市發展) and Millennium & Copthorne Hotels Ltd (千禧國敦酒店). Hong Leong Hotel Development is a subsidiary of Millennium, and both fall under the Hong Leong Group (豐隆集團). The Grand Hyatt Taipei (台北君悅大飯店), owned and built by
’WHITE BOX’: The open platform would give local firms access to Cisco’s cloud-based mobile network to develop 5G telecom equipment and tap into the global market The Ministry of Economic Affairs (MOEA) yesterday introduced a new 5G “open lab” in collaboration with US-based information technology and networking giant Cisco Systems Inc to address the rapidly growing “white box” 5G networking equipment market. The open lab will be a platform where Taiwanese manufacturers can access Cisco’s cloud-based mobile network to develop their own 5G telecom equipment, such as small-cell base stations, network switches, modems and Internet of things (IoT) devices, a ministry statement said. The open platform would allow Taiwanese manufacturers to tap into the lucrative 5G telecom equipment market, which was previously monopolized by Nokia Oyj, Ericsson AB
Nintendo Co is raising its target for Switch production to about 25 million units this fiscal year, people familiar with the matter said, as the ongoing COVID-19 pandemic keeps lifting demand and component shortages ease. The Kyoto, Japan-based company, which in April hiked orders to 22 million units by March next year, is asking partners to tack on another few million units, said the people, who did not want to be identified discussing internal goals. Assembly partners plan to work at maximum capacity through December. The new production target suggests that Nintendo is likely to outperform its Switch sales forecast of 19 million
‘BIG LOSS’: This year might see the last generation of Huawei’s Kirin chips, as their production would stop next month because they are made using US technology Chinese tech giant Huawei Technologies Co (華為) is running out of processor chips to make smartphones due to US sanctions and would be forced to stop production of its own most advanced chips, a company executive has said, in a sign of growing damage to Huawei’s business from US pressure. Huawei, one of the biggest producers of smartphones and network equipment, is at the center of US-Chinese tension over technology and security. Washington last year cut off Huawei’s access to US components and technology, and those penalties were tightened in May, when the White House barred vendors worldwide from using US